Prevalence and genotype distribution of cervical human papillomavirus DNA in Korean women: A multicenter study

Korean Journal of Pathology

Volumn 43, Issue 4, 2009, Pages 342-350

  Hong, Sung Ran ^a   KiM, In Sun ^b   Kim, Dong Won ^c   Kim, Mi Jin ^d   Kim, Ae Ree ^e   Kim, Young Ok ^f   Kim, Hye Sun ^g   Rha, Seo Hee ^g   Park, Gyeong Sin ^h   Park, Yong Koo ⁱ   Park, Yong Wook ^j   Park, Ho Sung ^k   Suh, Kwang Sun ^l   Sohn, Jin Hee ^m   Shin, Mi Kyung ⁿ   Oh, Hoon Kyu ^o   Yun, Ki Jung ^p   Yoon, Hye Kyoung ^q   Lee, Shi Nae ^r   Lee, Ah Won ^s   Lee, Hyo Jin ^t   Cho, Hyun Yee ^u   Choi, Chan ^v   Jung, Woon Won ^w   more..

^a Catholic Kwandong University   (South Korea)

^b College of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Kosin University College of Medicine   (South Korea)

^g Dong A University College of Medicine   (South Korea)

^h The Catholic University of Korea   (South Korea)

ⁱ Kyung Hee University College of Medicine   (South Korea)

^j Hanyang University Guri Hospital   (South Korea)

^k Chonbuk National University Medical School   (South Korea)

^l Chungnam National University College of Medicine   (South Korea)

^m Samsung Medical Center   (South Korea)

ⁿ Hallym University   (South Korea)

^o Catholic University of Daegu   (South Korea)

^p Wonkwang University   (South Korea)

^q Inje University College of Medicine   (South Korea)

^r Ewha Womans University School of Medicine   (South Korea)

^s The Catholic University of Korea   (South Korea)

^t National Police Hospital   (South Korea)

^u Gachon University   (South Korea)

^v Chonnam National University Research Institute of Medical Sciences   (South Korea)

^w Korea University   (South Korea)

more..

Author keywords

DNA chips; Human papillomavirus; Papanicolaou test; South Korea; Uterine cervix

Indexed keywords

EID: 70349835339     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2009.43.4.342     Document Type: Article

References (27)

1. Wallin KL, Wiklund F, Angström T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633-8.
2. Munoz N, Bosch FX, de Sanjose S, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
3. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003; 95: 46-52.
4. Wright TC Jr, Lorincz A, Ferris DG, et al. Reflex human papilloma- virus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998; 178: 962-6.
5. Symmans F, Mechanic L, MacConnell P, DaSilva K, Stricker B, Nuovo GJ. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol 1992; 11: 204-9.
6. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52: 342-62.
7. Guido R, Schiffman M, Solomon D, Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003; 188: 1401-5.
8. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB. Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003; 189: 295-304.
9. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57: 7-28.
10. de Sanjose S, Diaz M, Castellsague@ X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-9.
11. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73.
12. Jung WW, Chun T, Sul D, et al. Strategies against human papillo-mavirus infection and cervical cancer. J Microbiol 2004; 42: 255-66.
13. Hong SH, Lee DH, Shin HR. Prevalence of human papillomavirus infection in women in South Korea: incidence of positive HPV DNA and anti-VLPs in residents of Busan city. Korean J Cytopathol 2004; 15: 17-27.
14. Hwang T. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 1999; 14: 593-9.
15. Kahng J, Lee HJ. Clinical efficacy of HPV DNA Chip test in the era of HPV vaccination: 1,211 cases, a single institution study. Korean J Lab Med 2008; 28: 70-8.
16. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003; 97: 1672-80.
17. Sherman ME, Solomon D, Schiffman M. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol 2001; 116: 386-94.
18. Bandyopadhyay S, Austin RM, Dabbs D, Zhao C. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Arch Pathol Lab Med 2008; 132: 1874-81.
19. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92: 397-402.
20. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Post-menopausal squamous atypia: a spectrum including "pseudo-koilo-cytosis". Mod Pathol 1995; 8: 408-12.
21. Symmans F, Mechanic L, MacConnell P, DaSilva K, Stricker B, Nuovo GJ. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol 1992; 11: 204-9.
22. Solomon D, Schiffman M, Tarone R; ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-9.
23. Bae JH, Lee SJ, Kim CJ, et al. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008; 18: 788-94.
24. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-5.
25. Bao YP, Li N, Smith JS, Qiao YL, ACCPAB Members. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008; 18: 71-9.
26. Clifford GM, Gallus S, Herrero R, et al. IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991-8.
27. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1796-807.